Here's a breakdown of what the study found, how the protocol worked, and why this data matters
Dose-related effect Symptoms are most common during up-titration and often attenuate with time
In adults who lose 15% of body weight on a GLP-1 drug, that figure means a meaningful absolute reduction in muscle mass for a patient who may already be near the threshold of sarcopenia
Similarities and Differences Both Calocurb and GLP-1 receptor agonists help you shed pounds through the same basic mechanism: relying on activation of GLP-1 receptors to slow down stomach emptying and boost feelings of fullness, which leads to eating less
Wang EJ, Li Y, Lin M, et al
However, while the technology shows promise, current clinical data remains limited